✦ LIBER ✦

2P-0589 Influence of apolipoprotein E polymorphisms on coronary artery disease and on the efficacy of HMG-CoA reductase inhibitors in men

✍ Scribed by Maitland-van der Zee, A.H.; Jukema, J.W.; Zwinderman, A.H.; Hallman, D.M.; Seidell, J.C.; De Boer, A.; Kastelein, J.J.P.; De Knijff, P.; Hovingh, G.K.

Book ID: 118632117
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 63 KB
Volume: 4
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(03)90728-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of HMG-CoA reductase inhibito

The effect of HMG-CoA reductase inhibitor (CS-514) on the synthesis and secretion of apolipoproteins B and A-1 in the human hepatoblastoma Hep G2

✍ Ryuichiro Sato; Tsuneo Imanaka; Tatsuya Takano 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 612 KB

Independent effects of the −219 G>T and

Independent effects of the −219 G>T and ɛ2/ɛ3/ɛ4 polymorphisms in the apolipoprotein E gene on coronary artery disease: The Southampton Atherosclerosis Study

✍ Ye, Shu; Dunleavey, Louise; Bannister, Wendy; Day, Lorna B; Tapper, William; Col 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Effect of apolipoprotein E polymorphism

Effect of apolipoprotein E polymorphism on the serum lipid and insulin response to whole grain consumption in coronary artery disease patients

✍ Yangsoo Jang; Oh Yoen Kim∗; Hyun Young Park; Jong Ho Lee; Ji Sun Ham; Ha Jung Ry 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 59 KB

The HMG-CoA reductase inhibitor rosuvast

The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

✍ A. C. Calkin; S. Giunti; K. J. Sheehy; C. Chew; V. Boolell; Y. S. Rajaram; M. E. 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 420 KB

2P-0470 Influence of hypercholesterolemi

2P-0470 Influence of hypercholesterolemia and long-term HMG-CoA reductase inhibitors treatment on sE-selectin and sICAM-1 levels in hyperlipidemic patients without any other risk factor and CAD

✍ Panagoulis, N.C.; Perpinia, S.A.; Michelakakis, A.N.; Goudinakis, L.A.; Charbis, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Impact of P2Y12-ADP receptor polymorphis

Impact of P2Y12-ADP receptor polymorphism on the efficacy of clopidogrel dose-adjustment according to platelet reactivity monitoring in coronary artery disease patients

✍ Laurent Bonello; Nathalie Bonello-Palot; Sébastien Armero; Caroline Bonello; Oma 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 166 KB